Clinical Trial Update: Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol. [Phase 2]

View source ↗

Summary

Phase II clinical trial protocol assessing palliative short-course hypofractionated radiotherapy followed by chemotherapy for adenocarcinoma of the esophagus or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagus
• Esophagogastric Junction Adenocarcinoma

Snippet

Sponsor: Lund University Hospital | Conditions: Adenocarcinoma of the Esophagus or Esophagogastric Junction | Phase 2 | Status: COMPLETED